Authors: Badiee G, Kalantary A, Shafiei S, Hou J, Lazarus ME.
DOI: 10.7759/cureus.96452
Abstract Summary
Rare kidney disease linked to leukemia responds to targeted treatment. An 80-year-old with chronic lymphocytic leukemia developed immunotactoid glomerulopathy, causing protein loss and kidney injury. Chemotherapy targeting the underlying leukemia led to disease remission and restored kidney function, highlighting the importance of treating the root hematological cause.
Why Brain? ๐ง
Rare kidney disease linked to leukemia responds to cancer treatment. Case shows treating underlying chronic lymphocytic leukemia can reverse kidney damage and improve function in immunotactoid glomerulopathy.
Study Limitations:
Study limitations were not specified in the abstract.
License: cc by.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
